+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Stability Testing, Method Development & Validation), By End-use (Pharmaceutical Companies), By Country, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • March 2025
  • Region: Europe
  • Grand View Research
  • ID: 6062542
Description Jump to:
The Europe pharmaceutical analytical testing services in CRO market size was estimated at USD 2.3 billion in 2024 and is projected to grow at a CAGR of 8.34% from 2025 to 2030. The increasing demand for outsourcing analytical testing services among pharmaceutical companies, driven by stringent regulatory requirements and the need for cost-effective solutions, is a key factor contributing to market growth. Advancements in analytical testing are improving accuracy and efficiency, further supporting the market's expansion.

The industry has been advancing at a rapid pace due to an increasing demand for the analytical testing of biologics and biosimilars. The increasing incidence rate of chronic disorders such as inflammatory bowel diseases, cancer, and rheumatoid arthritis has emphasized the need for biologics.

The presence of advanced bioanalytical testing service facilities in Europe has led to noticeable improvements in areas such as drug development & clinical research, driving market expansion. These services comprise a vital aspect of the analysis of pharmaceutical compounds, such as biologics and small molecules, with leading providers offering methods such as immunoassays, chromatography, and biomarker analysis.

Technological advancements are improving the precision, efficiency, and cost-effectiveness of analytical testing services. Enhanced methodologies allow for comprehensive quality assessments, ensuring drug safety and efficacy throughout the development lifecycle. Growing investments in research and development, along with strategic collaborations between pharmaceutical companies and CROs, are expected to further drive market growth. With an increasing focus on regulatory compliance and streamlined drug development processes, the demand for analytical testing services is anticipated to rise steadily.

Europe Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the Europe pharmaceutical analytical testing services in CRO market report based on service, end use, and country:

Service Outlook (Revenue, USD Million, 2018 - 2030)

  • Bioanalytical Testing
  • Clinical
  • Non- Clinical
  • Method Development and Validation
  • Extractable and Leachable
  • Impurity Method
  • Technical Consulting
  • Other Method Validation Services
  • Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability Testing
  • Photostability Testing
  • Other Stability Testing Services
  • Other Testing Services

End Use (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Poland
  • Switzerland
  • Austria
  • Czech Republic
  • Croatia
  • Slovenia
  • Greece

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Europe Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Europe Pharmaceutical Analytical Testing Services in CRO Market: Service Business Analysis
4.1. Service Market Share, 2024 & 2030
4.2. Service Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market, 2018 - 2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market, 2018 - 2030 (USD Million)
4.4.3. Non- Clinical
4.4.3.1. Non- Clinical Market, 2018 - 2030 (USD Million)
4.5. Method Development and Validation
4.5.1. Method Development and Validation Market, 2018 - 2030 (USD Million)
4.5.2. Extractable and Leachable
4.5.2.1. Extractable and Leachable Market, 2018 - 2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market, 2018 - 2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market, 2018 - 2030 (USD Million)
4.5.5. Other Method Validation Services
4.5.5.1. Other Method Validation Services Market, 2018 - 2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market, 2018 - 2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market, 2018 - 2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market, 2018 - 2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market, 2018 - 2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market, 2018 - 2030 (USD Million)
4.6.6. Other Stability Testing Services
4.6.6.1. Other Stability Testing Services Market, 2018 - 2030 (USD Million)
4.7. Other Testing Services
4.7.1. Other Testing Services Market, 2018 - 2030 (USD Million)
Chapter 5. Europe Pharmaceutical Analytical Testing Services in CRO Market: End use Business Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Europe Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. Europe
6.4.1. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. UK Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. France Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Regulatory Framework
6.4.5.3. Competitive Insights
6.4.5.4. Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Regulatory Framework
6.4.6.3. Competitive Insights
6.4.6.4. Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.7. Norway
6.4.7.1. Key Country Dynamics
6.4.7.2. Regulatory Framework
6.4.7.3. Competitive Insights
6.4.7.4. Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Regulatory Framework
6.4.8.3. Competitive Insights
6.4.8.4. Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.9. Sweden
6.4.9.1. Key Country Dynamics
6.4.9.2. Regulatory Framework
6.4.9.3. Competitive Insights
6.4.9.4. Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Regulatory Framework
6.4.10.3. Competitive Insights
6.4.10.4. Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Regulatory Framework
6.4.11.3. Competitive Insights
6.4.11.4. Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Regulatory Framework
6.4.12.3. Competitive Insights
6.4.12.4. Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Regulatory Framework
6.4.13.3. Competitive Insights
6.4.13.4. Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Regulatory Framework
6.4.14.3. Competitive Insights
6.4.14.4. Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Regulatory Framework
6.4.15.3. Competitive Insights
6.4.15.4. Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Regulatory Framework
6.4.16.3. Competitive Insights
6.4.16.4. Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. SGS Société Générale de Surveillance SA
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Worldwide Clinical Trials
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Sofpromed
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. ClinChoice
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Evotec
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Eurofins Scientific
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. KYMOS Group
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. ViviaBiotech S.L.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. GalChimia
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. TCI Laboratories
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
7.5.11. Cotecna (NEOTRON SpA,)
7.5.11.1. Company Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic Initiatives
7.5.12. Tentamus
7.5.12.1. Company Overview
7.5.12.2. Financial Performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic Initiatives
7.5.13. Enzymlogic
7.5.13.1. Company Overview
7.5.13.2. Financial Performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic Initiatives
7.5.14. Pharmbiotest
7.5.14.1. Company Overview
7.5.14.2. Financial Performance
7.5.14.3. Product Benchmarking
7.5.14.4. Strategic Initiatives
7.5.15. UNIFARM - Research Centre
7.5.15.1. Company Overview
7.5.15.2. Financial Performance
7.5.15.3. Product Benchmarking
7.5.15.4. Strategic Initiatives
7.5.16. ANAPHARM EUROPE, S.L.U
7.5.16.1. Company Overview
7.5.16.2. Financial Performance
7.5.16.3. Product Benchmarking
7.5.16.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Europe pharmaceutical analytical testing services in CRO market, by region, 2018 - 2030 (USD Million)
Table 4 Europe pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 5 Europe pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 6 Europe pharmaceutical analytical testing services in CRO market, by country, 2018 - 2030 (USD Million)
Table 7 UK pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 8 UK pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 9 Germany pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 10 Germany pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 11 France pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 12 France pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 13 Italy pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 14 Italy pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 15 Spain pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 16 Spain pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 17 Norway pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 18 Norway pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 19 Denmark pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 20 Denmark pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 21 Sweden pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 22 Sweden pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 23 Poland pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 24 Poland Pharmaceutical Analytical Testing Services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 25 Switzerland pharmaceutical analytical testing services in CRO market, by Service, 2018 - 2030 (USD Million)
Table 26 Switzerland pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 27 Austria pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 28 Austria pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 29 Czech Republic pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 30 Czech Republic pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 31 Croatia pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 32 Croatia pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 33 Slovenia pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 34 Slovenia pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
Table 35 Greece pharmaceutical analytical testing services in CRO market, by service, 2018 - 2030 (USD Million)
Table 36 Greece pharmaceutical analytical testing services in CRO market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Europe pharmaceutical analytical testing services in CRO: Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation Services
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Service, end use and application outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Europe pharmaceutical analytical testing services in CRO: Market dynamics
Fig. 12 Europe pharmaceutical analytical testing services in CRO market: Porter’s five forces analysis
Fig. 13 Europe pharmaceutical analytical testing services in CRO market: PESTLE analysis
Fig. 14 Europe pharmaceutical analytical testing services in CRO market: Service segment dashboard
Fig. 15 Europe pharmaceutical analytical testing services in CRO market: Service market share analysis, 2024 & 2030
Fig. 16 Bioanalytical testing market, 2018 - 2030 (USD Million)
Fig. 17 Clinical market, 2018 - 2030 (USD Million)
Fig. 18 Non- Clinical market, 2018 - 2030 (USD Million)
Fig. 19 Method development and validation market, 2018 - 2030 (USD Million)
Fig. 20 Extractable and leachable market, 2018 - 2030 (USD Million)
Fig. 21 Impurity method market, 2018 - 2030 (USD Million)
Fig. 22 Technical consulting market, 2018 - 2030 (USD Million)
Fig. 23 Other method validation services market, 2018 - 2030 (USD Million)
Fig. 24 Stability testing market, 2018 - 2030 (USD Million)
Fig. 25 Drug substance market, 2018 - 2030 (USD Million)
Fig. 26 Stability indicating method validation market, 2018 - 2030 (USD Million)
Fig. 27 Accelerated stability testing market, 2018 - 2030 (USD Million)
Fig. 28 Photostability testing market, 2018 - 2030 (USD Million)
Fig. 29 Other stability testing services market, 2018 - 2030 (USD Million)
Fig. 30 Other testing services market, 2018 - 2030 (USD Million)
Fig. 31 Europe pharmaceutical analytical testing services in CRO market: End use segment dashboard
Fig. 32 Europe pharmaceutical analytical testing services in CRO market: End use market share analysis, 2024 & 2030
Fig. 33 Pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 34 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 35 Others market, 2018 - 2030 (USD Million)
Fig. 36 Europe pharmaceutical analytical testing services in CRO market revenue, by region
Fig. 37 Regional marketplace: Key takeaways
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Europe pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 40 UK country dynamics
Fig. 41 UK pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 42 Germany country dynamics
Fig. 43 Germany pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 44 France country dynamics
Fig. 45 France pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 46 Italy country dynamics
Fig. 47 Italy pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 48 Spain country dynamics
Fig. 49 Spain pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 50 Norway country dynamics
Fig. 51 Norway pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 52 Sweden country dynamics
Fig. 53 Sweden pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 54 Denmark country dynamics
Fig. 55 Denmark pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 56 Poland country dynamics
Fig. 57 Poland pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 58 Switzerland country dynamics
Fig. 59 Switzerland pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 60 Austria country dynamics
Fig. 61 Austria pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 62 Czech Republic country dynamics
Fig. 63 Czech Republic pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 64 Croatia country dynamics
Fig. 65 Croatia pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 66 Slovenia country dynamics
Fig. 67 Slovenia pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 68 Greece country dynamics
Fig. 69 Greece pharmaceutical analytical testing services in CRO market, 2018 - 2030 (USD Million)
Fig. 70 Company categorization
Fig. 71 Company market position analysis
Fig. 72 Strategic framework

Companies Mentioned

  • SGS Société Générale de Surveillance SA
  • Worldwide Clinical Trials
  • Sofpromed
  • ClinChoice
  • Evotec
  • Eurofins Scientific
  • KYMOS Group
  • ViviaBiotech S.L.
  • GalChimia
  • TCI Laboratories
  • Cotecna (NEOTRON SpA,)
  • Tentamus
  • Enzymlogic
  • Pharmbiotest
  • UNIFARM - Research Centre
  • ANAPHARM EUROPE, S.L.U

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages90
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.73 Billion
Compound Annual Growth Rate8.3%
Regions CoveredEurope
No. of Companies Mentioned16

Related Topics

Related Reports

U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2023 - 2030 - Product Image

U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2023 - 2030

  • Report
  • 122 Pages
  • United States
From
India Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing), By Model Type, By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2024 - 2030 - Product Image

India Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing), By Model Type, By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2024 - 2030

  • Report
  • 80 Pages
  • India
From
U.S. Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourcing), By Test Type, By End-use, By Sample (Sterile Drugs, Biologics & Therapeutics), And Segment Forecasts, 2022 - 2030 - Product Image

U.S. Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourcing), By Test Type, By End-use, By Sample (Sterile Drugs, Biologics & Therapeutics), And Segment Forecasts, 2022 - 2030

  • Report
  • 100 Pages
  • United States
From
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Service, By Therapeutic Area, By Molecule, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Service, By Therapeutic Area, By Molecule, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
U.S. Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By Model Type, By Technology, By End-use, By State, And Segment Forecasts, 2024 - 2030 - Product Image

U.S. Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By Model Type, By Technology, By End-use, By State, And Segment Forecasts, 2024 - 2030

  • Report
  • 80 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.